SAN
92.06
+2.59%↑
SHL.DE
49.22
+0.94%↑
ARGX
503
+3.65%↑
FRE
42.91
+0.73%↑
ONC.US
228.61
+1.33%↑
SAN
92.06
+2.59%↑
SHL.DE
49.22
+0.94%↑
ARGX
503
+3.65%↑
FRE
42.91
+0.73%↑
ONC.US
228.61
+1.33%↑
SAN
92.06
+2.59%↑
SHL.DE
49.22
+0.94%↑
ARGX
503
+3.65%↑
FRE
42.91
+0.73%↑
ONC.US
228.61
+1.33%↑
SAN
92.06
+2.59%↑
SHL.DE
49.22
+0.94%↑
ARGX
503
+3.65%↑
FRE
42.91
+0.73%↑
ONC.US
228.61
+1.33%↑
SAN
92.06
+2.59%↑
SHL.DE
49.22
+0.94%↑
ARGX
503
+3.65%↑
FRE
42.91
+0.73%↑
ONC.US
228.61
+1.33%↑
24h
Aktuell
Min
113.25
Max
117
Einkommen | -142M 667M |
---|---|
Verkäufe | 152M 5.4B |
KGV Branchendurchschnitt | 26.27 56.602 |
EPS | 2.2 |
Dividendenrendite | 1.34 |
Gewinnspanne | 12.311 |
EBITDA | 85M 1.6B |
Empfehlungen | Buy |
---|---|
12-Monats-Prognose | +42.4% upside |
Dividendenrendite Branchendurchschnitt | 1.34% 2.45% |
---|---|
Nächstes Ergebnis | 7. Aug. 2025 |
Marktkapitalisierung | 33B 98B |
---|---|
Vorheriger Eröffnungskurs | 115.66 |
Vorheriger Schlusskurs | 114.45 |
By Acuity
30%
70%
80 / 382 Ranking in Healthcare
By Trading Central
Vertrauen
Strong Bearish Evidence
121.15 / 123.55 Unterstützung & Widerstand
Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.
15. Mai 2025, 08:36 UTC
Merck KGaA Shares Plunge After Outlook Cut on Tariff, Currency Risks
DJ
Lesen
15. Mai 2025, 05:25 UTC
Merck KGaA Cuts Outlook Amid Macroeconomic Challenges
DJ
Lesen
28. Apr. 2025, 11:25 UTC
Germany's Merck to Buy SpringWorks for $3.9 Billion -- Update
DJ
Lesen
28. Apr. 2025, 06:41 UTC
Germany's Merck Set to Buy SpringWorks in $3.9 Billion Deal
DJ
Lesen
15. Mai 2025, 08:21 UTC
Merck KGaA Shares Slide After Outlook Cut on Tariff, Currency Risks
DJ
Lesen
15. Mai 2025, 06:53 UTC
Merck KGaA's Guidance Cut Should Cause Share-Price Pressure -- Market Talk
DJ
Lesen
15. Mai 2025, 05:00 UTC
Merck KGaA: Guidance Cut Reflects Impact of Current Macro-Economic, Geopolitical Environment
DJ
Lesen
15. Mai 2025, 05:00 UTC
Merck KGaA 1Q EBITDA EUR1.48B
DJ
Lesen
15. Mai 2025, 05:00 UTC
Merck KGaA Had Seen 2025 Net Sales Between EUR21.5B and EUR22.9B
DJ
Lesen
15. Mai 2025, 05:00 UTC
Merck KGaA Now Expects 2025 Net Sales Between EUR20.9B and EUR22.4B
DJ
Lesen
15. Mai 2025, 05:00 UTC
Merck KGaA Now Sees 2025 EBITDA Before One-Time Items Between EUR5.8B and EUR6.4B
DJ
Lesen
15. Mai 2025, 05:00 UTC
Merck KGaA Had Seen 2025 EBITDA Before One-Time Items Between EUR6.1B and EUR6.6B
DJ
Lesen
15. Mai 2025, 05:00 UTC
Analysts Saw Merck KGaA 1Q Adj EPS at EUR2.17
DJ
Lesen
15. Mai 2025, 05:00 UTC
Merck KGaA Cuts 2025 View
DJ
Lesen
15. Mai 2025, 05:00 UTC
Merck KGaA 1Q After-Tax Profit EUR738M
DJ
Lesen
15. Mai 2025, 05:00 UTC
Merck KGaA 1Q Adj EPS EUR2.12
DJ
Lesen
15. Mai 2025, 05:00 UTC
Merck KGaA 1Q Sales EUR5.28B
DJ
Lesen
15. Mai 2025, 05:00 UTC
Analysts Saw Merck KGaA 1Q Ebitda Before One-Time Items EUR1.51B
DJ
Lesen
15. Mai 2025, 05:00 UTC
Merck KGaA 1Q EBIT EUR1.01B
DJ
Lesen
15. Mai 2025, 05:00 UTC
Merck KGaA 1Q Ebitda Before One-Time Items EUR1.535B
DJ
Lesen
15. Mai 2025, 05:00 UTC
Analysts Saw Merck KGaA 1Q Net Sales at EUR5.28B
DJ
Lesen
28. Apr. 2025, 15:20 UTC
Merck KGaA's $3.9B SpringWorks Therapeutics Buy Underwhelms -- Market Talk
DJ
Lesen
28. Apr. 2025, 09:20 UTC
Stocks to Watch Monday: DoorDash, Merck, Spirit AeroSystems, Airbus -- WSJ
DJ
Lesen
28. Apr. 2025, 08:36 UTC
Germany's Merck's Deal to Acquire SpringWorks Makes Strategic Sense, but Price in Focus -- Market Talk
DJ
Lesen
28. Apr. 2025, 06:06 UTC
Germany's Merck: Acquisition Will Strengthen Merck Healthcare Presence in U.S.
DJ
Lesen
28. Apr. 2025, 06:05 UTC
Germany's Merck: Planned Acquisition Will Immediately Add Revenue, Accelerate Growth
DJ
Lesen
28. Apr. 2025, 06:05 UTC
Germany's Merck: Deal Is for Purchase Price of $47 a Share in Cash
DJ
Lesen
28. Apr. 2025, 06:04 UTC
Germany's Merck to Buy SpringWorks for About $3.9B
DJ
Lesen
28. Apr. 2025, 06:02 UTC
Germany's Merck to Buy SpringWorks Therapeutics
DJ
Lesen
24. Apr. 2025, 22:51 UTC
Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- Update
DJ
Lesen
Kursveränderung
By TipRanks
12-Monats-Prognose
Durchschnitt 164.33 EUR 42.4%
Hoch 190 EUR
Tief 107 EUR
Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Merck KGaA – Dist angeboten haben.
By TipRanks
Buy
10 ratings
8
Buy
1
Halten
1
Sell
Basierend auf 10 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Merck KGaA – Dist abgegeben haben.
By Trading Central
Kurzfristig
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Mittelfristig
Neutral Evidence
The bullish and bearish events are balanced.
Langfristig
Bearish Evidence
All events are bearish.
By Acuity
Nachrichtenstimmung
Bullische Evidenz
Volatilität
Unterdurchschnittlich
Nachrichtenvolumen (RCV)
Überdurchschnittlich
Vertriebs- und Verwaltungskosten
Betriebsaufwand
Gewinn vor Steuern
Verkäufe
Umsatzkosten
Bruttogewinn aus dem Verkauf
Zinsaufwand für Schulden
EBITDA
Betriebsergebnis
$